Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Sherpa Healthcare Partners Announces Close of Oversubscribed Fund 2020-07-28 11:33
Clarity Pharmaceuticals opens SARTATE neuroblastoma clinical trial 2020-07-23 21:13
GenScript launches CDMO segment "GenScript ProBio" at inaugural GenScript Cell and Gene Therapy Industry Development & Cooperation Forum 2020-07-21 22:04
Clarity Pharmaceuticals and ImaginAb to Collaborate on New Cancer Targets 2020-07-21 21:13
Samsung Biologics Expands Drug Product Manufacturing Facility in Incheon 2020-07-21 10:13
New Early Breast Cancer Drug Now Approved in Malaysia 2020-07-17 06:16
I-Mab Announces Authorization of Stock Repurchase Program up to $20 Million 2020-07-16 04:15
Samsung Biologics and ImmuneOncia sign multi-product development and manufacturing agreement 2020-07-15 13:46
Fosun Pharma Announces its Licensed COVID-19 Vaccine Product Receives Acceptance Notice of Clinical Trial Application by NMPA 2020-07-14 20:00
Samsung Biologics signs additional development and manufacturing agreement with STCube 2020-07-12 08:00
Carromex Unveils Pharma Leads, a Groundbreaking Cloud-based Platform for Rapid Drug Analysis and Discovery 2020-07-10 11:31
Asieris Received China NMPA's Approval to Start a Global Phase III Clinical Trial for APL-1702 to Treat Cervical Precancerous Lesions (HSIL) 2020-07-08 22:00
ILIAS Biologics Granted Key Patent for Exosome-based Drug Delivery System in the United States 2020-07-08 01:00
­Antengene Corporation Appoints Former BMS Senior Leader of Biostatistics Zhinuan YU as Corporate Vice President of Biometrics and Regulatory Enabling Functions 2020-07-02 08:16
Transcenta Announces First Patient Dosed in Phase I Clinical Trial of Claudin18.2 Targeting Monoclonal Antibody TST001 in the US 2020-07-01 23:00
Coronavirus Breakthrough: New Study Highlights Senhwa Biosciences Silmitasertib as Potential Treatment for COVID-19 2020-07-01 21:00
'Curing Cancer without Surgery' 2020-06-30 15:10
Alterity Therapeutics meeting with US FDA provides development pathway for ATH434 2020-06-30 11:14
China Biologic Provides Additional Comments on the Xinjiang Deyuan and Shuanglin Transaction 2020-06-29 13:00
Mayne Pharma Announces FDA Filing Acceptance of New Drug Application for E4/DRSP in the US 2020-06-24 12:10
1 112 113 114 115 116 159